Neurocrine Biosciences (NBIX) Retained Earnings (2016 - 2021)
Historic Retained Earnings for Neurocrine Biosciences (NBIX) over the last 12 years, with Q3 2021 value amounting to -$628.5 million.
- Neurocrine Biosciences' Retained Earnings rose 4144.23% to -$628.5 million in Q3 2021 from the same period last year, while for Sep 2021 it was -$628.5 million, marking a year-over-year increase of 4144.23%. This contributed to the annual value of -$725.4 million for FY2020, which is 3595.83% up from last year.
- Per Neurocrine Biosciences' latest filing, its Retained Earnings stood at -$628.5 million for Q3 2021, which was up 4144.23% from -$651.0 million recorded in Q2 2021.
- Over the past 5 years, Neurocrine Biosciences' Retained Earnings peaked at -$628.5 million during Q3 2021, and registered a low of -$1.3 billion during Q1 2019.
- In the last 5 years, Neurocrine Biosciences' Retained Earnings had a median value of -$1.2 billion in 2019 and averaged -$1.1 billion.
- As far as peak fluctuations go, Neurocrine Biosciences' Retained Earnings tumbled by 2255.46% in 2017, and later soared by 4144.23% in 2021.
- Quarter analysis of 5 years shows Neurocrine Biosciences' Retained Earnings stood at -$1.2 billion in 2017, then increased by 1.76% to -$1.2 billion in 2018, then increased by 3.83% to -$1.1 billion in 2019, then soared by 35.96% to -$725.4 million in 2020, then grew by 13.36% to -$628.5 million in 2021.
- Its Retained Earnings stands at -$628.5 million for Q3 2021, versus -$651.0 million for Q2 2021 and -$693.3 million for Q1 2021.